Form 4: UnitedHealth Group CFO Receives Dividend Equivalents on Restricted Stock Units

John F. Rex, President and CFO of UnitedHealth Group Inc., reported the acquisition of 131.931 shares of common stock as dividend equivalents on outstanding restricted stock units.

Summary

• John F. Rex, President and Chief Financial Officer of UnitedHealth Group Inc. (UNH), reported a transaction on June 24, 2025.
• The transaction involved the acquisition of 131.931 shares of UnitedHealth Group common stock.
• These shares represent dividend equivalents paid on Mr. Rex's outstanding restricted stock units (RSUs).
• The dividend equivalents were acquired at a price of $0 per share, indicating they were not purchased but granted as part of the RSU terms.
• These dividend equivalents are subject to the same vesting terms as the underlying RSUs and will be forfeited if the RSUs do not vest.
• Following this transaction, Mr. Rex directly beneficially owns 203,898.467 shares of common stock.
• Additionally, 6,791 shares are indirectly beneficially owned by a trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine compensation-related transaction (dividend equivalents on RSUs), which is expected and indicates continued executive alignment with company performance. There are no negative implications from this specific filing.

Positives

• The acquisition of dividend equivalents indicates that John F. Rex continues to hold a significant number of restricted stock units, aligning his interests with long-term shareholder value.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, suggesting a pre-arranged and systematic approach to equity compensation.

Negatives

• This Form 4 filing primarily reports a routine compensation-related transaction and does not contain information that would typically be considered negative.

Risks

• The dividend equivalents are subject to forfeiture if the underlying restricted stock units do not vest, which is a standard risk associated with performance-based equity compensation.

Future Outlook

This document is a Form 4 filing reporting an insider transaction and does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

This Form 4 filing details a routine compensation-related transaction for a senior executive at a major healthcare company. Such transactions are common across the healthcare industry as part of executive compensation packages designed to align management incentives with shareholder interests. It does not provide broader industry trends or competitive insights.

Related Party Transactions

• The transaction involves the acquisition of shares by a key executive (John F. Rex, President & CFO) from the company as part of his compensation, which is a common form of related party dealing in the context of executive compensation.

Stakeholder Impact

• Shareholders: The transaction reflects a standard component of executive compensation, aligning the CFO's interests with long-term company performance through equity holdings. It does not directly impact share price in a significant way.
• Employees: No direct impact on general employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Keywords

UnitedHealth Group, UNH, SEC Form 4, Insider Transaction, John F. Rex, CFO, Restricted Stock Units, Dividend Equivalents, Equity Compensation, Corporate Governance